Abstract:Rui Deng, * Juan Lu, * Xiong Liu, Xiao-Hong Peng, Jie Wang, Xiang-Ping Li Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China *These authors contributed equally to this work Correspondence: Xiang-Ping Li Department of Otolaryngology-Head and Neck Surgery, Nanfang Hospital, 1838 North of Guangzhou Avenue, Guangzhou, People's Republic of China Tel +86-20-61642001 Fax +86-20-87703645 Email li321162@qq.com Purpose: Tumour-associated macrophages (TAMs) are the most abundant immune cells in the tumor microenvironment and provide a barrier against the cytotoxic effector functions of T cells and natural killer (NK) cells. Recently, TAMs have become increasingly recognised as an attractive target in combination therapy with PD-1/PD-L1 immuno-checkpoint blockades (ICBs). However, the relationship between PD-L1 expression and TAMs remains unknown in nasopharyngeal carcinoma (NPC). Patients and Methods: A total of 212 NPC patients from Nanfang hospital were collected in this study. We evaluated the expression of PD-L1 in tumor cells, CD68 (pan-macrophages), and CD163 (M2-like macrophage) in NPC tissues using immunohistochemical (IHC) staining. Results: The positivity of PD-L1 on tumor cells was 61.3% (130/212). The infiltration densities of CD68+ cells and CD163+ cells in PD-L1-positive NPC tissues were significantly higher than those in PD-L1-negative NPC tissues ( P =0.0012 for CD68; P < 0.0001 for CD163). Logistic regression analysis showed that high densities of CD68+ macrophages and CD163+ TAMs were significantly associated with increased PD-L1 expression. Subgroup analyses demonstrated that a positive PD-L1 expression on tumor cells in combination with lower CD163+ TAMs density was significantly associated with favorable prognosis, whereas negative PD-L1 expression on tumor cells with higher CD163+ TAMs density was associated with worse prognosis. Conclusion: The PD-L1 expression in tumor cells was positively correlated with TAMs density in tumor microenvironment of NPC, suggesting TAMs as a new target for combination therapy to improve the response rate of ICBs in NPC treatment. Keywords: nasopharyngeal carcinoma, PD-L1, tumor-associated macrophage, prognosis, tumor microenvironment

Elevated DLL4 Expression is Correlated with VEGF and Predicts Poor Prognosis of Nasopharyngeal Carcinoma

Influence of Up-Regulation of Notch Ligand DLL4 on Biological Behaviors of Human Gastric Cancer Cells.

Overexpressions of DLL4 and CD105 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

Expression of programmed death ligand-1 predicts poor outcome in nasopharyngeal carcinoma

Decreased Expression of the NKG2D Ligand ULBP4 May Be an Indicator of Poor Prognosis in Patients with Nasopharyngeal Carcinoma

Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment

Relationship between dysregulation of STAT 4 and clinicopathological significance in nasopharyngeal carcinoma

Expression and Clinical Significance of Programmed Death Ligand 1 in Nasopharyngeal Carcinoma.

Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma

Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome

Expression and Role of Delta-like 4 in Pancreatic Cancer

Lymphocyte activating gene 3 protein expression in nasopharyngeal carcinoma is correlated with programmed cell death-1 and programmed cell death ligand-1, tumor-infiltrating lymphocytes

High Expression of FGFR4 Enhances Tumor Growth and Metastasis in Nasopharyngeal Carcinoma

High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma

A novel proteomic prognostic signature characterizes the immune landscape and predicts nasopharyngeal carcinoma prognosis

Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma

Genetic and Epigenetic Alterations of DLC-1, a Candidate Tumor Suppressor Gene, in Nasopharyngeal Carcinoma.

Expression of CD44V6 Protein in Nasopharyneal Carcinoma

Downregulated ECRG4 is Correlated with Lymph Node Metastasis and Predicts Poor Outcome for Nasopharyngeal Carcinoma Patients

PD-L1 Expression is Highly Associated with Tumor-Associated Macrophage Infiltration in Nasopharyngeal Carcinoma

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis